None
DE
Bristol Myers Squibb (NYSE:BMY) Issues FY 2026 Earnings Guidance
['Ethan Ryder']
Ticker Report
Bristol Myers Squibb (NYSE:BMY – Get Free Report) updated its FY 2026 earnings guidance on Thursday.
Get Bristol Myers Squibb alerts:Bristol Myers Squibb (NYSE:BMY – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th.
Bristol Myers Squibb had a return on equity of 64.87% and a net margin of 15.01%.Bristol Myers Squibb has set its FY 2026 guidance at 6.750-7.000 EPS.
Bristol Myers Raises Earnings Guidance as Newer Drugs Drive Big Quarterly BeatInstitutional Investors Weigh In On Bristol Myers SquibbSeveral institutional investors have recently modified their holdings of BMY.
Featured StoriesReceive News & Ratings for Bristol Myers Squibb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bristol Myers Squibb and related companies with MarketBeat.com's FREE daily email newsletter.